MANGOCEUTICALS, INC.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
MGRX$0.20+1.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
The following exhibits are filed herewith or incorporated by reference herein:
| Incorporated by Reference | ||||||
|---|---|---|---|---|---|---|
| Exhibit Number | Description of Exhibit | Filed/ Furnished Herewith | Form | Exhibit | Filing Date | File Number |
| 2.1♦ | Business Combination Agreement, dated July 29, 2026, by and among Mangoceuticals, Inc., Nuclea Energy Inc., the principal shareholders of Nuclea, and the principal shareholders of Mango.* | 8-K | 2.1 | 7/30/2026 | 001-41615 | |
| 3.1 | Amendment to Bylaws of Mangoceuticals, Inc. (Amendment to Section 3.8), effective July 28, 2026. | 8-K | 3.1 | 7/30/2026 | 001-41615 | |
| 10.1# | Mangoceuticals, Inc. Amendment to Stock Option Agreements (Jacob Cohen), dated March 16, 2026 | - | 8-K | 10.1 | 3/25/2026 | 001-41615 |
| 10.2# | Clarification Agreement dated May 18, 2026, entered into between Mangoceuticals, Inc. and Jacob Cohen | 10-Q | 10.2 | 5/19/2025 | 001-41615 | |
| 10.3 | Form of Common Stock Subscription Agreement | 8-K | 10.1 | 7/2/2026 | 001-41615 | |
| 10.4# | Release and Separation Agreement between Mangoceuticals, Inc. and Jacob D. Cohen | 8-K | 10.1 | 7/30/2026 | 001-41615 | |
| 31.1* | Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act | X | ||||
| 31.2* | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act | X | ||||
| 32.1** | Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act | X | ||||
| 32.2** | Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act | X | ||||
| 101.INS* | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | X | ||||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document | X | ||||
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | X | ||||
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document | X | ||||
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||
| 104* | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set | X | ||||
- Filed herewith.
** Furnished herewith.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.